Your mission

The Stability Manager is responsible for managing all aspects of the stability program across all projects and UK and Ireland sites, including initiating and managing stability studies, protocol development and maintenance, data monitoring, trending and reporting.

Job Description

Major Activities

Designs, coordinate, and execute stability studies for clinical and commercial gene therapy products according to regulatory guidelines and company protocols.
Generate stability reports by applying analytical testing expertise to ensure scientific and technical excellence. Utilize statistical software like JMP to perform rigorous statistical analyses, ensuring robust interpretation of data and adherence to regulatory standards.
Authors, reviews, revises, and approves SOP's, stability protocols and reports, memo’s, regulatory and specification documents (as required).
The Stability Manager will also assist with leading the functionality and maintenance of stability related processes and systems.
Drives continuous improvement activities for the stability programs.
Ensures that the GMP stability program continuously aligns with FDA, ICH and other international agencies.
Manages Quality Systems records for QC Stability- creates, assesses, reviews Deviations, Change Controls, CAPA's and other applicable stability-related investigations and events.
Guide and work with others to identify opportunities for continuous improvement and implement/maintain solutions.
Provide strong teamwork in establishing a quality culture and shared accountability. Ensure GMP compliance is built into the design and implementation of processes and systems, including tracking metrics to monitor and improve performance.
Responsible for ensuring that own work and that of the team complies with GMP, Data Integrity and Good Documentation Practice (GDP) and is undertaken in accordance with applicable procedures
Responsible for ensuring that own training and that of the team is undertaken in a timely and GMP compliant manner before the task is undertaken.
Responsible for ensuring that any GMP documentation e.g. (but not limited to) Issues, CAPAs, Change Controls, BMRs & audit/inspection actions, within own area of responsibility, is closed timely and in a RFT state.

Job Background

5 years of relevant industry experience in Pharma / Biotech industry required.
Strong understanding of gene therapy stability principles, including degradation pathways, accelerated stability testing, and shelf-life determination.
Proven experience in managing staff.
Demonstrated proficiency and expertise in various analytical methodologies, particularly in the context of stability testing and assessment of biologics or gene therapy.
Solid understanding of relevant FDA, EU, and ICH regulatory guidelines and pharmacopeia as applicable to stability study design, expiry dating, and analytical method qualification/validation for biologics and gene therapy.
Solid understanding and hands-on experience of applying basic statistical tools for stability data trending and rate analysis to support retest period/ shelf-life proposals.
Attention to detail and excellent skills in record keeping / documentation.
Experience in IND, NDA and BLA submission is highly preferred.
Strong interpersonal skills; ability to communicate effectively both verbally and in written formats.
Solid understanding of product development activities in biotech/drug/gene therapy development, including key interdependencies, and knowledge of proven development strategies and tactics.
To travel to other Meira sites when required.

Why us?

About us

MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. We currently have six programs in clinical development including three ocular indications, a salivary gland condition, and a Parkinson’s disease program. Our initial focus on diseases of the eye, salivary gland and central nervous system is based on the significant unmet medical need coupled with the high potential gene therapy has to provide meaningful clinical benefit in these areas. With headquarters in New York and London, our global footprint provides us the opportunity to partner with leading institutions around the world, allowing us to deepen our understanding of diseases and their progression.

Our team was built with deep expertise in gene therapy development, allowing us to efficiently advance our programs from preclinical to clinical development. Our core capabilities in viral vector design and optimization and gene therapy manufacturing give us a differentiated approach to developing gene therapies. Additionally, we are developing proprietary technology to potentially enable innovative gene therapy treatments whose expression can be turned on and off with an easily administered small molecule. We believe temporal control of gene therapy products has the potential to transform the gene therapy landscape.

Our state-of-the-art manufacturing facility, completed in early 2018, was designed to meet global regulatory requirements, including the current good manufacturing practices (cGMP) required by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the U.S. Food and Drug Administration (FDA). The 29,000-square foot facility has the flexibility and capacity to produce sufficient product for all our clinical trials and will scale to commercial capacity.

QC Stability Manager

Job Description